Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

489
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
489
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

477
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
477
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

539
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
539
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

589
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
589
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

807
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
807

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk, Predictors, and Outcomes of Acute Kidney Injury in Patients Admitted to Intensive Care Units in Egypt.

Scientific reports·2017
Same author

Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients.

Cardiorenal medicine·2017
Same author

Obesity and kidney disease: Hidden consequences of the epidemic.

African journal of primary health care & family medicine·2017
Same author

Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2017
Same author

Optimizing hypertension management in renal transplantation: a call to action.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2017
Same author

Optimizing hypertension management in renal transplantation: a call to action.

Journal of hypertension·2017

Related Experiment Video

Updated: Mar 3, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K

Chronic Fluid Overload and Mortality in ESRD.

Carmine Zoccali1, Ulrich Moissl2, Charles Chazot3

  • 1Center of Clinical Physiology, Clinical Epidemiology of Renal Diseases and Hypertension, Reggio Calabria, Italy; carmine.zoccali@tin.it.

Journal of the American Society of Nephrology : JASN
|May 6, 2017
PubMed
Summary

Fluid overload (FO) in end-stage renal disease (ESRD) patients on hemodialysis significantly increases mortality risk. Chronic FO exposure is a major predictor of death across all systolic blood pressure categories, highlighting the need for fluid status monitoring.

Keywords:
ESRDEpidemiology and outcomesVOLUME EXPANSIONblood pressurehemodialysismortality risk

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.3K
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.8K

Related Experiment Videos

Last Updated: Mar 3, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.3K
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.8K

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Clinical Epidemiology

Background:

  • Sustained fluid overload (FO) is a known contributor to hypertension, heart failure, and mortality in patients with end-stage renal disease (ESRD) undergoing maintenance hemodialysis.
  • Previous research has not established a clear link between chronic FO exposure and mortality in this vulnerable patient group.

Purpose of the Study:

  • To investigate the relationship between baseline and cumulative fluid overload (FO) exposure over one year and mortality risk in incident ESRD patients.
  • To analyze this relationship across different systolic blood pressure (syst-BP) categories.

Main Methods:

  • A cohort study involving 39,566 incident ESRD patients from a large international dialysis network.
  • Whole-body bioimpedance spectroscopy was used to assess fluid status, with over 200,000 FO measurements recorded.
  • Statistical analyses examined mortality risk associated with baseline and cumulative FO across three syst-BP categories (<130, 130-160, >160 mmHg).

Main Results:

  • Both baseline and cumulative 1-year FO exposure were significant predictors of excess mortality across all studied systolic blood pressure categories (P<0.001).
  • Cumulative FO exposure demonstrated a stronger association with increased death risk compared to baseline FO.
  • Hazard ratios for mortality increased with higher levels of FO, irrespective of blood pressure control.

Conclusions:

  • Chronic fluid overload in ESRD patients is a substantial risk factor for mortality, independent of blood pressure levels.
  • The findings suggest that fluid status monitoring may be more beneficial than relying solely on predialysis blood pressure measurements for managing ESRD patients.
  • Further clinical trials are warranted to compare the efficacy of fluid status-guided versus blood pressure-guided treatment policies in ESRD.